These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30902655)

  • 1. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.
    Garceau D; Chauret N
    Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
    Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
    Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
    Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
    Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
    [No Abstract]   [Full Text] [Related]  

  • 4. DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough.
    Pelleg A; Xu F; Zhuang J; Undem B; Burnstock G
    Ther Adv Respir Dis; 2019; 13():1753466619877960. PubMed ID: 31558105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough.
    Muccino D; Green S
    Pulm Pharmacol Ther; 2019 Jun; 56():75-78. PubMed ID: 30880151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S-600918 and its analogue DDTPA.
    Wang DP; Zhang M; Li M; Yang XN; Li C; Cao P; Zhu MX; Tian Y; Yu Y; Lei YT
    Br J Pharmacol; 2024 Apr; 181(8):1203-1220. PubMed ID: 37921202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young men.
    Friedrich C; Singh D; Francke K; Klein S; Hetzel T; Zolk O; Gashaw I; Scheerans C; Morice A
    Br J Clin Pharmacol; 2024 Aug; 90(8):2004-2018. PubMed ID: 38775025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.
    Richards D; Gever JR; Ford AP; Fountain SJ
    Br J Pharmacol; 2019 Jul; 176(13):2279-2291. PubMed ID: 30927255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DT-0111: a novel P2X3 receptor antagonist.
    Pelleg A; Sirtori E; Rolland JF; Mahadevan A
    Purinergic Signal; 2023 Sep; 19(3):467-479. PubMed ID: 36944825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
    Gever JR; Soto R; Henningsen RA; Martin RS; Hackos DH; Panicker S; Rubas W; Oglesby IB; Dillon MP; Milla ME; Burnstock G; Ford AP
    Br J Pharmacol; 2010 Jul; 160(6):1387-98. PubMed ID: 20590629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.
    Abdulqawi R; Dockry R; Holt K; Layton G; McCarthy BG; Ford AP; Smith JA
    Lancet; 2015 Mar; 385(9974):1198-205. PubMed ID: 25467586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in mice.
    Vandenbeuch A; Larson ED; Anderson CB; Smith SA; Ford AP; Finger TE; Kinnamon SC
    J Physiol; 2015 Mar; 593(5):1113-25. PubMed ID: 25524179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.
    Shcherbatko A; Foletti D; Poulsen K; Strop P; Zhu G; Hasa-Moreno A; Melton Witt J; Loo C; Krimm S; Pios A; Yu J; Brown C; Lee JK; Stroud R; Rajpal A; Shelton D
    J Biol Chem; 2016 Jun; 291(23):12254-70. PubMed ID: 27129281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study.
    Friedrich C; Francke K; Gashaw I; Scheerans C; Klein S; Fels L; Smith JA; Hummel T; Morice A
    Clin Pharmacokinet; 2022 Aug; 61(8):1143-1156. PubMed ID: 35624408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.
    Smith JA; Kitt MM; Morice AH; Birring SS; McGarvey LP; Sher MR; Li YP; Wu WC; Xu ZJ; Muccino DR; Ford AP;
    Lancet Respir Med; 2020 Aug; 8(8):775-785. PubMed ID: 32109425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study.
    Morice AH; Kitt MM; Ford AP; Tershakovec AM; Wu WC; Brindle K; Thompson R; Thackray-Nocera S; Wright C
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31023843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2X3 antagonist P1, P5-di[inosine-5'] pentaphosphate binds to the desensitized state of the receptor in rat dorsal root ganglion neurons.
    Ford KK; Matchett M; Krause JE; Yu W
    J Pharmacol Exp Ther; 2005 Oct; 315(1):405-13. PubMed ID: 16014755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X3 and P2X2/3 receptors activation induces articular hyperalgesia by an indirect sensitization of the primary afferent nociceptor in the rats' knee joint.
    Teixeira JM; Parada CA; Tambeli CH
    Eur J Pharmacol; 2020 Jul; 879():173054. PubMed ID: 32145326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough.
    High B; Jetté ME; Li M; Ramakrishnan VR; Clary M; Prager J; Draf J; Hummel T; Finger TE
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37057093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dioxotriazine derivatives as a new class of P2X
    Kai H; Horiguchi T; Kameyama T; Asahi K; Endoh T; Jikihara S; Hasegawa T; Tanaka S; Nozu A; Takeyama C; Tomari M; Takahashi F; Tamura N; Yagi S; Itoh T; Isou Y
    Bioorg Med Chem Lett; 2021 Apr; 37():127833. PubMed ID: 33540044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.